Traumatic spinal cord injury (SCI) triggers a robust inflammatory response consisting of activated neutrophils, macrophages, astrocytes, T cells and B cells. The magnitude and timing of the immune response vary depending upon the spinal level of injury (thoracic vs. cervical), injury severity, species and strain, age at the time of injury, and mode of injury (i.e. contusion, compression or ischemic). Regardless of these factors, however, these immune responses persist after SCI and contribute to pathological and reparative processes. Throughout this chapter, we will discuss the role that individual aspects of the innate and adaptive immune responses may be playing in repair or pathology after SCI. Where appropriate, current clinical therapies targeting these immune response will be highlighted.
|Title of host publication||Neuroinflammation and CNS Disorders|
|Number of pages||23|
|State||Published - Jun 3 2014|
Bibliographical notePublisher Copyright:
© 2014 John Wiley & Sons, Ltd. All rights reserved.
- B cell
- Clinical trial
- Spinal cord injury
- T cell
ASJC Scopus subject areas
- Medicine (all)
- Neuroscience (all)